Therapy of Lupus Nephritis

New England Journal of Medicine

Volumn 314, Issue 10, 1986, Pages 614-619

  Austin, Howard A ^a   Klippel, John H ^b   Balow, James E ^b   le Riche, Nicole G h ^b   Steinberg, Alfred D ^b   Plotz, Paul H ^b   Decker, John L ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; PREDNISONE;

ADVERSE DRUG REACTION; BLADDER; BLOOD AND HEMOPOIETIC SYSTEM; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSIS; DRUG COMPARISON; DRUG THERAPY; GLOMERULONEPHRITIS; HEMORRHAGIC CYSTITIS; HERPES ZOSTER; HUMAN; INFERTILITY; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SEPSIS; THERAPY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADMINISTRATION, ORAL; ADULT; AZATHIOPRINE; BIOPSY; CLINICAL TRIALS; CREATININE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDNISONE; RANDOM ALLOCATION;

EID: 0022578857     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198603063141004     Document Type: Article

References (39)

1. Steinberg AD, Kaltreider HB, Staples PJ, Goetzl EJ, Talal N, Decker JL. Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med 1971; 75: 165–71.
2. Sztejnbok M, Stewart A, Diamond H, Kaplan D. Azathioprine in the treatment of systemic lupus erythematosus: a controlled study. Arthritis Rheum 1971; 14: 639–45.
3. Donadio JV Jr, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC. Treatment of lupus nephritis with prednisone and combine prednisone and azathioprine. Ann Intern Med 1972; 77: 829–35.
4. Cade R, Spooner G, Schlein E, et al. Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 1973; 10: 37–56.
5. Steinberg AD, Decker JL. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis. Arthritis Rheum 1974; 17: 923–37.
6. Donadio JV Jr, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC. Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthritis Rheum 1974; 17: 573–81.
7. Decker JL, Klippel JH, Plotz PH, Steinberg AD. Cyclophosphamide or azathioprine in lupus glomerulonephritis: a controlled trial: results at 28 months. Ann Intern Med 1975; 83: 606–15.
8. Hahn BH, Kantor OS, Osterland CK. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus: report of a prospective controlled trial in 24 patients. Ann Intern Med 1975; 83: 597–605.
9. Donadio JV Jr, Holley KE, Ferguson RH, Ilstrup DM. Progressive lupus glomerulonephritis: treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc 1976; 51: 484–94.
10. Donadio. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 1978; 299: 1151–5.
11. Klippel JH. Studies in the treatment of lupus nephritis. In: Decker JL, moderator. Systemic lupus erythematosus: evolving concepts. Ann Intern Med 1979; 91: 587–604.
12. Donadio JV Jr, Holley KE, Ilstrup DM. Adrenocorticoid and cytotoxic drug treatment of lupus nephropathy. In: Zurukzoglu W, Papadimitriou M, Pyrpasopoulos M, Sion M, Zamboulis C, eds. Advances in basic and clinical nephrology. Basel: S Karger, 1981:643–8.
13. Dinant HJ, Decker JL, Klippel JH, Balow JE, Plotz PH, Steinberg AD. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann Intern Med 1982; 96: 728–36.
14. Carette S, Klippel JH, Decker JL, et al. Controlled studies of oral immunosuppressive drugs in lupus nephritis: a long-term follow-up. Ann Intern Med 1983; 99: 1–8.
15. Felson DT, Anderson J. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis: results of a pooled analysis. N Engl J Med 1984; 311: 1528–33.
16. Balow JE, Austin HA III, Muenz LR, et al. Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 1984; 311: 491–5.
17. Austin HA III, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 1983; 75: 382–91.
18. Diagnostic and Therapeutic Criteria Committee, American Rheumatism Association. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971; 21: 643–8.
19. Pirani CL, Salinas-Madrigal L. Evaluation of percutaneous renal biopsy. Pathol Annu 1968; 3: 249–96.
20. McCluskey RT. Lupus nephritis. In: Sommers SC, ed. Pathology decennial. New York: Appleton–Century–Crofts, 1975:435–60.
21. Churg J, Sobin LH. Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin, 1982.
22. Austin HA III, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689–95.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
24. Benedetti J, Yuen K, Young L. Life tables and survival functions. In: Dixon WJ, ed. BMDP statistical software. Berkeley, Calif.: University of California Press, 1981:557–75.
25. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–70.
26. Pollak VE, Pirani CL, Schwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med 1964; 63: 537–50.
27. Zweiman B, Kornblum J, Cornog J, Hildreth EA. The prognosis of lupus nephritis: role of clinical-pathologic correlations. Ann Intern Med 1968; 69: 441–53.
28. Striker GE, Kelly MR, Quadracci LJ, Scribner BH. The course of lupus nephritis: a clinical-pathological correlation of fifty patients. In: Kincaid-Smith P, Mathew T, Becker EL, eds. Glomerulonephritis. New York: John Wiley, 1973:1141–66.
29. Fries JF, Weyl S, Holman HR. Estimating prognosis in systemic lupus erythematosus. Am J Med 1974; 57: 561–5.
30. Hecht B, Siegel N, Adler M, Kashgarian M, Hayslett JP. Prognostic indices in lupus nephritis. Medicine (Baltimore) 1976; 55: 163–81.
31. Morel-Maroger L, Mery JP, Droz D, et al. The course of lupus nephritis: contribution of serial renal biopsies. Adv Nephrol 1976; 6: 79–118.
32. Baldwin DS, Gluck MC, Lowenstein J, Gallo G. Lupus nephritis: clinical course as related to morphologic forms and their transitions. Am J Med 1977; 62: 12–30.
33. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine (Baltimore) 1978; 57: 371–410.
34. Kimberly RP, Lockshin MD, Sherman RL, Beary JF, Mouradian J, Cheigh JS. “End-stage” lupus nephritis: clinical course to and outcome on dialysis. Medicine (Baltimore) 1981; 60: 277–87.
35. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601–11.
36. Whiting-O'Keefe Q, Henke JE, Shearn MA, Hopper J Jr, Biava CG, Epstein WV. The information content from renal biopsy in systemic lupus erythematosus: stepwise linear regression analysis. Ann Intern Med 1982; 96: 718–23.
37. Walport MJ, Hubbard WN, Hughes GRV. Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br Med J 1982; 285: 769–70.
38. Scott DGI, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 1984; 76: 377–84.
39. Steinberg AD, Plotz PH, Wolff SM, Wong VG, Agus SG, Decker JL. Cytotoxic drugs in treatment of nonmalignant diseases. Ann Intern Med 1972; 76: 619–42.